Almac Diagnostics Services ClaraT Total mRNA Report

Almac Diagnostic Services of Craigavon, Northern Ireland, is launching the complete version of its ClaraT Total mRNA Report at the European Society for Medical Oncology meeting in Barcelona this weekend. The report content has expanded from an initial version launched a year ago, Almac said, and now includes 92 gene expression signatures, 100 single-gene drug targets, and more than 7,000 additional biology-linked genes categorized by 10 hallmarks of cancer. The research-use-only product uses RNA sequencing alongside proprietary bioinformatics to provide investigators with an interactive report that facilitates visualization of novel molecular subgroups within a sample cohort and key discriminating biology in individual tumor samples, the company said.